Insider Trading & Ownership - Sethuraman Natarajan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sethuraman Natarajan
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2024-11-29
Sale		 2024-12-03
5:24 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
President, Research & Develop.		 15,891 $20.18 $320,620 144,997
(Direct)		 View
2024-11-11
Sale		 2024-11-13
4:49 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
President, Research & Develop.		 4,109 $20.03 $82,300 160,888
(Direct)		 View
2024-11-04
Sale		 2024-11-06
4:36 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
President, Research & Develop.		 18,219 $18.62 $339,281 164,997
(Direct)		 View
2024-10-16
Sale		 2024-10-18
4:31 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
President, Research & Develop.		 600 $18 $10,800 183,216
(Direct)		 View
2024-09-06
Sale		 2024-09-10
4:32 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 3,242 $15.12 $49,004 183,816
(Direct)		 View
2024-07-12
Sale		 2024-07-16
4:43 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 1,238 $18 $22,284 188,814
(Direct)		 View
2024-05-16
Sale		 2024-05-20
5:26 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 18,980 $15.16 $287,695 190,052
(Direct)		 View
2023-07-10
Sale		 2023-07-12
4:32 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 17,878 $18.03 $322,389 153,447
(Direct)		 View
2023-04-17
Sale		 2023-04-19
6:06 pm		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 3,961 $18 $71,316 171,325
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2025-03-03
Tax Withholding		 2025-03-04
4:58 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
President, Research & Develop.		 6,138 $11.68 290,459
(Direct)		 View
2025-03-01
Option Award		 2025-03-04
4:58 pm		 N/A
2035-03-01		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
President, Research & Develop.		 151,600 $0 290,459
(Direct)		 View
2024-09-04
Tax Withholding		 2024-09-05
6:47 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 955 $15.42 187,058
(Direct)		 View
2024-09-03
Tax Withholding		 2024-09-05
6:47 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 14 $17.7 187,058
(Direct)		 View
2024-09-05
Tax Withholding		 2024-09-05
6:47 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 167 $15.13 187,058
(Direct)		 View
2024-09-03
Tax Withholding		 2024-09-05
6:47 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 151 $16.93 187,058
(Direct)		 View
2024-09-03
Tax Withholding		 2024-09-05
6:47 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 469 $15.76 187,058
(Direct)		 View
2024-03-04
Tax Withholding		 2024-03-05
7:44 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 347 $12.42 275,832
(Direct)		 View
2024-03-05
Tax Withholding		 2024-03-05
7:44 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 1,505 $12.28 275,832
(Direct)		 View
2024-03-04
Tax Withholding		 2024-03-05
7:44 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 414 $13.37 275,832
(Direct)		 View
2024-03-01
Option Award		 2024-03-05
7:44 pm		 N/A
2034-03-01		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 110,900 $0 275,832
(Direct)		 View
2023-09-05
Tax Withholding		 2023-09-06
5:09 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 449 $14.46 188,698
(Direct)		 View
2023-09-01
Option Award		 2023-09-06
5:09 pm		 N/A
2033-09-01		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 35,700 $0 188,698
(Direct)		 View
2023-03-01
Option Award(A)		 2023-04-19
5:50 pm		 N/A
2033-03-01		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 35,700 $0 196,786
(Direct)		 View
2023-03-02
Tax Withholding		 2023-03-03
4:36 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 1,058 $11.6 232,486
(Direct)		 View
2023-03-01
Option Award		 2023-03-03
4:36 pm		 N/A
2033-03-01		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 71,400 $0 232,486
(Direct)		 View
2022-09-01
Option Award		 2022-09-06
4:33 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 5,794 $0 162,144
(Direct)		 View
2022-07-01
Option Award		 2022-07-06
4:16 pm		 N/A
2032-07-01		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 34,763 $0 34,763
(Direct)		 View
2022-03-01
Option Award		 2022-03-03
4:10 pm		 N/A
2032-03-01		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 81,113 $0 225,875
(Direct)		 View
2021-10-28
Option Award		 2021-11-01
7:02 pm		 N/A
2031-10-28		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 243,639 $0 243,639
(Direct)		 View

Ownership		 2021-10-28
9:01 pm		 N/A
N/A		 Entrada Therapeutics Inc. TRDA Sethuraman Natarajan
Chief Scientific Officer		 0 $0 323,881
(Direct)		 View
(A) Indicate amendment filing.